{"DataElement":{"publicId":"6369439","version":"1","preferredName":"Measurable Non-Measurable Neoplasm Assessment Lesion Type","preferredDefinition":"The anatomic site of a non/measureable lesion within the patient.","longName":"LES_TYP","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"6369430","version":"1","preferredName":"Measurable Non-Measurable Neoplasm Assessment","preferredDefinition":"Capable of being measured._Not possible to be measured._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The final result of a determination of the value, significance, or extent of.","longName":"Meas_Non_Neoplsm_Ass","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6369428","version":"1","preferredName":"Measurable Non-Measurable Neoplasm","preferredDefinition":"Capable of being measured.:Not possible to be measured.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C37894:C25589:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurable","conceptCode":"C37894","definition":"Capable of being measured.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Non-Measurable","conceptCode":"C25589","definition":"Not possible to be measured.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71BFA799-4A28-3DD8-E053-F662850AEE51","latestVersionIndicator":"Yes","beginDate":"2018-07-24","endDate":null,"createdBy":"LEEW","dateCreated":"2018-07-24","modifiedBy":"ONEDATA","dateModified":"2018-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2465182","version":"1","preferredName":"Assessed","preferredDefinition":"Having determined the value, significance, or extent of.","longName":"C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F836E72-26FF-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-03-22","modifiedBy":"ONEDATA","dateModified":"2006-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71BFA799-4A36-3DD8-E053-F662850AEE51","latestVersionIndicator":"Yes","beginDate":"2018-07-24","endDate":null,"createdBy":"LEEW","dateCreated":"2018-07-24","modifiedBy":"TANGL","dateModified":"2018-08-03","changeDescription":"AREN1721 WL 7/24/2018","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6369431","version":"1","preferredName":"Lesion Type","preferredDefinition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._Something distinguishable as an identifiable class based on common qualities.","longName":"Lesi_Type","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"500","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":"Bone lesion","ValueMeaning":{"publicId":"2565819","version":"1","preferredName":"Bone lesion","longName":"2565819","preferredDefinition":"Bone lesion","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CE28-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-03-20","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-03-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"728EAFF9-0EC1-6F6A-E053-F662850A1EC2","beginDate":"2018-07-24","endDate":null,"createdBy":"TANGL","dateCreated":"2018-08-03","modifiedBy":"ONEDATA","dateModified":"2018-08-03","deletedIndicator":"No"},{"value":"5","valueDescription":"Organomegaly Abdominal","ValueMeaning":{"publicId":"6369437","version":"1","preferredName":"Organomegaly Abdominal","longName":"6369437","preferredDefinition":"An abnormal enlargement of an organ, particularly an organ of the abdominal cavity.: Of, or related to, the abdomen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Organomegaly","conceptCode":"C121827","definition":"An abnormal enlargement of an organ, particularly an organ of the abdominal cavity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Abdominal","conceptCode":"C25342","definition":"Of, or related to, the abdomen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71C0C02C-DB15-7579-E053-F662850A226E","latestVersionIndicator":"Yes","beginDate":"2018-07-24","endDate":null,"createdBy":"LEEW","dateCreated":"2018-07-24","modifiedBy":"ONEDATA","dateModified":"2018-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"728EAFF9-0E97-6F6A-E053-F662850A1EC2","beginDate":"2018-07-24","endDate":null,"createdBy":"TANGL","dateCreated":"2018-08-03","modifiedBy":"ONEDATA","dateModified":"2018-08-03","deletedIndicator":"No"},{"value":"6","valueDescription":"Ascites","ValueMeaning":{"publicId":"5446318","version":"1","preferredName":"Ascites","longName":"5446318","preferredDefinition":"The accumulation of fluid in the peritoneal cavity, which may be serous, hemorrhagic, or the result of tumor metastasis to the peritoneum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peritoneal Effusion","conceptCode":"C2885","definition":"The accumulation of fluid in the peritoneal cavity, which may be serous, hemorrhagic, or the result of tumor metastasis to the peritoneum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B8D33E4-B487-3A9F-E050-BB89AD435846","latestVersionIndicator":"Yes","beginDate":"2016-09-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-09-02","modifiedBy":"JKNABLE","dateModified":"2023-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"728EAFF9-0EAB-6F6A-E053-F662850A1EC2","beginDate":"2018-07-24","endDate":null,"createdBy":"TANGL","dateCreated":"2018-08-03","modifiedBy":"ONEDATA","dateModified":"2018-08-03","deletedIndicator":"No"},{"value":"2","valueDescription":"Cystic Lesion","ValueMeaning":{"publicId":"5868257","version":"1","preferredName":"Cystic Lesion","longName":"5868257","preferredDefinition":"A pathologic process that contains a single or multiple sac-like spaces.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cystic Lesion","conceptCode":"C41421","definition":"A pathologic process that contains a single or multiple sac-like spaces.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"51F07FD0-96B0-7F8C-E053-F662850A9C00","latestVersionIndicator":"Yes","beginDate":"2017-06-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-06-14","modifiedBy":"ONEDATA","dateModified":"2017-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"728EAFF9-0ED5-6F6A-E053-F662850A1EC2","beginDate":"2018-07-24","endDate":null,"createdBy":"TANGL","dateCreated":"2018-08-03","modifiedBy":"ONEDATA","dateModified":"2018-08-03","deletedIndicator":"No"},{"value":"7","valueDescription":"Breast Disorder Inflammatory","ValueMeaning":{"publicId":"6369436","version":"1","preferredName":"Breast Disorder Inflammatory","longName":"6369436","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the breast. Representative examples of non-neoplastic disorders include fibrocystic disease, gynecomastia, and mastitis. Representative examples of neoplastic disorders include fibroadenoma, lobular neoplasia, carcinoma, lymphoma, and sarcoma.: Relating to inflammation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Disorder","conceptCode":"C26709","definition":"A non-neoplastic or neoplastic disorder that affects the breast. Representative examples of non-neoplastic disorders include fibrocystic disease, gynecomastia, and mastitis. Representative examples of neoplastic disorders include fibroadenoma, lobular neoplasia, carcinoma, lymphoma, and sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Inflammatory","conceptCode":"C25535","definition":"Relating to inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71C0C02C-DAE5-7579-E053-F662850A226E","latestVersionIndicator":"Yes","beginDate":"2018-07-24","endDate":null,"createdBy":"LEEW","dateCreated":"2018-07-24","modifiedBy":"ONEDATA","dateModified":"2018-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"728EAFF9-0EEB-6F6A-E053-F662850A1EC2","beginDate":"2018-07-24","endDate":null,"createdBy":"TANGL","dateCreated":"2018-08-03","modifiedBy":"ONEDATA","dateModified":"2018-08-03","deletedIndicator":"No"},{"value":"8","valueDescription":"Leptomeningeal Neoplasm","ValueMeaning":{"publicId":"6369433","version":"1","preferredName":"Leptomeningeal Neoplasm","longName":"6369433","preferredDefinition":"A malignant neoplasm that has spread from its original site to the two innermost layers of tissue that cover the brain and spinal cord.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leptomeningeal Neoplasm","conceptCode":"C4958","definition":"A malignant neoplasm that has spread from its original site to the two innermost layers of tissue that cover the brain and spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71C0C02C-DA97-7579-E053-F662850A226E","latestVersionIndicator":"Yes","beginDate":"2018-07-24","endDate":null,"createdBy":"LEEW","dateCreated":"2018-07-24","modifiedBy":"ONEDATA","dateModified":"2018-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"728EAFF9-0F01-6F6A-E053-F662850A1EC2","beginDate":"2018-07-24","endDate":null,"createdBy":"TANGL","dateCreated":"2018-08-03","modifiedBy":"ONEDATA","dateModified":"2018-08-03","deletedIndicator":"No"},{"value":"3","valueDescription":"Prior Therapeutic Procedure Lesion","ValueMeaning":{"publicId":"6369438","version":"1","preferredName":"Prior Therapeutic Procedure Lesion","longName":"6369438","preferredDefinition":"Earlier in time or order.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.: A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71C0C02C-DB50-7579-E053-F662850A226E","latestVersionIndicator":"Yes","beginDate":"2018-07-24","endDate":null,"createdBy":"LEEW","dateCreated":"2018-07-24","modifiedBy":"ONEDATA","dateModified":"2018-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"728EAFF9-0F17-6F6A-E053-F662850A1EC2","beginDate":"2018-07-24","endDate":null,"createdBy":"TANGL","dateCreated":"2018-08-03","modifiedBy":"ONEDATA","dateModified":"2018-08-03","deletedIndicator":"No"},{"value":"9","valueDescription":"Skin Lung Lymphangitic Carcinomatosis","ValueMeaning":{"publicId":"6369435","version":"1","preferredName":"Skin Lung Lymphangitic Carcinomatosis","longName":"6369435","preferredDefinition":"An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.: One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.: Extensive infiltration of the lymphatic vessels by cancer cells, resulting in widespread cancer dissemination.  The lymphatic vessels appear as palpable, cord-like structures, especially in skin areas overlying the carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin","conceptCode":"C12470","definition":"An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lymphangitic Carcinomatosis","conceptCode":"C3870","definition":"Extensive infiltration of the lymphatic vessels by cancer cells, resulting in widespread cancer dissemination.  The lymphatic vessels appear as palpable, cord-like structures, especially in skin areas overlying the carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71C0C02C-DABF-7579-E053-F662850A226E","latestVersionIndicator":"Yes","beginDate":"2018-07-24","endDate":null,"createdBy":"LEEW","dateCreated":"2018-07-24","modifiedBy":"ONEDATA","dateModified":"2018-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"728EAFF9-0F2D-6F6A-E053-F662850A1EC2","beginDate":"2018-07-24","endDate":null,"createdBy":"TANGL","dateCreated":"2018-08-03","modifiedBy":"ONEDATA","dateModified":"2018-08-03","deletedIndicator":"No"},{"value":"4","valueDescription":"Malignant Lymph Node Neoplasm","ValueMeaning":{"publicId":"6160855","version":"1","preferredName":"Malignant Lymph Node Neoplasm","longName":"6160855","preferredDefinition":"A primary or metastatic malignant tumor involving the lymph node.  Lymphomas and metastatic carcinomas are representative examples. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Lymph Node Neoplasm","conceptCode":"C35812","definition":"A primary or metastatic malignant tumor involving the lymph node.  Lymphomas and metastatic carcinomas are representative examples.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68F7AA8C-EC3B-1FCD-E053-F662850A8E10","latestVersionIndicator":"Yes","beginDate":"2018-04-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-04-03","modifiedBy":"ONEDATA","dateModified":"2018-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"728EAFF9-0F43-6F6A-E053-F662850A1EC2","beginDate":"2018-07-24","endDate":null,"createdBy":"TANGL","dateCreated":"2018-08-03","modifiedBy":"ONEDATA","dateModified":"2018-08-03","deletedIndicator":"No"},{"value":"99","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"728EAFF9-0F4D-6F6A-E053-F662850A1EC2","beginDate":"2018-07-24","endDate":null,"createdBy":"TANGL","dateCreated":"2018-08-03","modifiedBy":"ONEDATA","dateModified":"2018-08-03","deletedIndicator":"No"},{"value":"10","valueDescription":"Pericardial Effusion Pleural","ValueMeaning":{"publicId":"6369432","version":"1","preferredName":"Pericardial Effusion Pleural","longName":"6369432","preferredDefinition":"Fluid collection within the pericardial sac, usually due to inflammation.: Of or pertaining to the pleura.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pericardial Effusion","conceptCode":"C3319","definition":"Fluid collection within the pericardial sac, usually due to inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pleural","conceptCode":"C25223","definition":"Of or pertaining to the pleura.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71C0C02C-DA74-7579-E053-F662850A226E","latestVersionIndicator":"Yes","beginDate":"2018-07-24","endDate":null,"createdBy":"LEEW","dateCreated":"2018-07-24","modifiedBy":"ONEDATA","dateModified":"2018-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"728EAFF9-0F63-6F6A-E053-F662850A1EC2","beginDate":"2018-07-24","endDate":null,"createdBy":"TANGL","dateCreated":"2018-08-03","modifiedBy":"ONEDATA","dateModified":"2018-08-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3271385","version":"1","preferredName":"Lesion Type","preferredDefinition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.:Type; a subdivision of a particular kind of thing.","longName":"C3824:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACD63232-B0D0-12DE-E040-BB89AD4341CB","latestVersionIndicator":"Yes","beginDate":"2011-09-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-13","modifiedBy":"ONEDATA","dateModified":"2011-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71C0C02C-DA51-7579-E053-F662850A226E","latestVersionIndicator":"Yes","beginDate":"2018-07-24","endDate":null,"createdBy":"LEEW","dateCreated":"2018-07-24","modifiedBy":"TANGL","dateModified":"2018-08-03","changeDescription":"AREN1721 WL 7/24/2018","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Lesion Type","type":"Preferred Question Text","description":"Lesion Type","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71C0C02C-DBA3-7579-E053-F662850A226E","latestVersionIndicator":"Yes","beginDate":"2018-07-24","endDate":null,"createdBy":"LEEW","dateCreated":"2018-07-24","modifiedBy":"TANGL","dateModified":"2018-08-03","changeDescription":"AREN1721 WL 7/24/2018","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}